Putting Patients First: Kirk Taylor on Clinical Trials, Trust, and Access to Medicines

In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Kirk Taylor, a physician, neurologist, and life sciences executive whose career has spanned leading pharmaceutical companies, emerging biotech organizations, and public-sector leadership.

Drawing on decades of experience at Pfizer, Biogen, Sanofi Genzyme, EMD Serono, and other life sciences organizations, Dr. Taylor currently serves as Chief Medical Officer at the CLL Society. He shares lessons from a career at the intersection of medicine, clinical development, and business leadership. He discusses what early-stage biotechs need to build in-house, when to rely on external partners, and how to make sound decisions when clinical data are promising but inconclusive. Dr. Taylor also explains why patient access and affordability must be considered early in drug development. We hope you enjoyed this week’s episode of Clinical Trialblazers. Please
take a moment to rate and review this podcast wherever you listen.

Special thanks to our production partner, Wonder Media Network. Our
producer is Brittany Martinez, our editor is Gianna Palmer and our
production assistant is Joia Putnoi.